James J. Burns & Company »

Crispr Therapeutics shares owned by James J. Burns & Company

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by James J. Burns & Company from 13F filings

Historical chart of James J. Burns & Company investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by James J. Burns & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by James J. Burns & Company

Quarter filed Position value Share count Share price at filing
2026-06-30 $210k 3.9k 54.54

More positions owned by James J. Burns & Company

Vanguard Index Fds Large Cap Etf (VV)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Allspring Exchange Traded Fu Broad Market Cor (AFIX)
Vanguard Index Fds Extend Mkt Etf (VXF)
Vanguard Star Fds Vg Tl Intl Stk F (VXUS)
Ishares Tr Core Us Aggbd Et (AGG)
Apple (AAPL)
First Tr Exchng Traded Fd Vi Actv Fctr Smcp (AFSM)
Schwab Strategic Tr Us Brd Mkt Etf (SCHB)
Vaneck Etf Trust Mrngstr Wde Moat (MOAT)
Schwab Strategic Tr Us Lcap Gr Etf (SCHG)
Ishares Tr Core Msci Eafe (IEFA)
Vanguard Index Fds Mid Cap Etf (VO)
Schwab Strategic Tr Us Aggregate B (SCHZ)
Vanguard Index Fds Small Cp Etf (VB)

View all positions for James J. Burns & Company

Top funds holding Crispr Therapeutics

ARK Investment Management
BlackRock
Orbis Allan Gray
Capital World Investors
State Street Corporation
GSK
Geode Capital Management
Sr One Capital Management
Two Sigma Investments
FMR
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
EcoR1 Capital
UBS Group
Capital Research and Management Company - Division 3

View all funds holding Crispr Therapeutics